Report by MDC Financial Research

MDC's “Event-Driven Legal℠" Weekly Report summarises near-term legal events including analysis on their potential as share-price catalysts for the indicated companies. Recent coverage includes:

Arbutus Biopharma and Genevant Sciences recently filed Patent Infringement Lawsuit against Moderna seeking licensing fees for the manufacture and sale of Moderna’s vaccine for COVID-19.

IDT Corporation's Defense of a shareholder lawsuit challenging the repurchase of an Indemnification Claim from Straight Path Communications that spared it from having to pay $614m in FCC fines.

Sonos and Alphabet's continuing battles at the US International Trade Commission and US District Courts.

Healthcare

Report by MDC Financial Research

ABUS should experience high volatility when the US Court of Appeals for the Federal Circuit issues its Decisions in Appellate Case Numbers: 20-1184 & 20-2329. Although Decisions may still be a few months away, these Patents relate to a Nucleic Acid delivery system comprising of a composite of multiple lipids. This delivery system appears to have ranges that overlap with Moderna's recent Covid-19 Vaccine; and therefore, ABUS may have grounds for an eventual Patent Infringement lawsuit.